Topical Antibiotics Market

Topical Antibiotics Market (Drug Class: Tetracycline, Aminoglycosides, Erythromycin, Clindamycin, and Others; Dosage Form: Ointments, Creams, Powder, Gels, and Others; Indication: Skin Infection, Eye Infection, Bromhidrosis, and Others; Product Type: Prescription and OTC; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Growing Prevalence of Skin Infections Worldwide to Aid Market Growth

Topical antibiotics have emerged as a popular drug class for the treatment and management of a range of medical conditions. Among different indications such as the skin, eye, and Bromhidrosis, the use of topical antibiotics to fight bacterial skin infection has witnessed consistent growth over the past few decades– a trend that is expected to continue over the upcoming years. Research and development activities around the world are likely to fuel the growth of the global topical antibiotics market, as new topical antibiotics continue to enter the market. While the growing popularity of antiseptics could potentially hinder market growth, the growing awareness pertaining to the benefits of topical antibiotics is anticipated to boost the demand.

At present, drug developers and other stakeholders involved in the global topical antibiotics market are increasingly focusing on addressing various issues related to the use of topical antibiotics, including increasing rate of bacterial resistance and local hypersensitivity. In the current scenario, topical antibiotics are one of the most prescribed antimicrobial agents worldwide. Europe and North America are projected to provide lucrative opportunities to the market players involved in the topical antibiotics market landscape due to a robust healthcare infrastructure in these regions, growing investments for drug development and research, etc.

These factors, along with the growing emphasis on identifying more indications for which topical antibiotics are likely to be effective are expected to propel the growth of the market for the topical antibiotics market during the assessment period. The global topical antibiotics market is anticipated to attain a market value of US$ 8.3 Bn by the end of 2030.

To know the scope of our report Get a Sample on Topical Antibiotics Market

Drug Developers Focus on Increasing Efficacy of Topical Antibiotics

Over the past few decades, the demand for topical antibiotics has witnessed considerable growth at a consistent rate. However, despite the impressive growth rate in terms of adoption, market players are increasingly focusing on addressing the various challenges involved in the use of topical antibiotics. Research and development activities across the topical antibiotics market landscape are projected to primarily focus on improving the clinical efficacy of these drugs. In addition, the entry of new and emerging agents, including ebselen and retapamulin will provide an immense boost to the overall prospects of the global topical antibiotics market during the assessment period. Despite the growing use of topical antibiotics, there is a growing need to address the increasing bacterial resistance among patients in a few settings due to which, the efficacy of these drugs is compromised. In addition, the ecological impact of topical antibiotics is another area of concern due to which, research activities have gained momentum.

Get a glimpse of the in-depth analysis through our Report Brochure

The clinical usage of topical antibiotics, particularly in developed regions of the world is projected to grow at a commendable pace in the upcoming years. However, the Asia Pacific region is expected to provide abundant opportunities for market players during the latter half of the forecast period.

Demand to Remain Lower than Usual amid COVID-19 Pandemic

Although skin infections continue to affect millions of individuals around the world, at present, the global healthcare sector is primarily focusing and engaged in curbing the transmission of the novel coronavirus infection. In addition, research and development activities are also aiming at the development of a vaccine. However, the production and development of topical antibiotics are likely to remain unaffected around the world, as drug manufacturers and the pharmaceutical sector are exempted from lockdown measures enforced by governments worldwide.

Although the production is expected to remain unaffected, the demand for topical antibiotics could see a decline amid the COVID-19 pandemic. Although the growth is expected to remain slower than usual, the market is expected to show signs of recovery in the last quarter of 2020.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global topical antibiotics market is expected to grow at a sluggish CAGR of ~3% during the forecast period. The market growth can be primarily attributed to a host of factors, including growing focus on improving the efficacy of topical antibiotics, growing investments toward research & development activities, entry of new and emerging topic antibiotics agents, and the considerable surge in the number of skin infections around the world. Market players should focus on addressing challenges put forward by topical antibiotics such as increasing bacterial resistance, catastrophic ecological impact, etc. While North America and Europe are likely to remain at the forefront in terms of market share and value, the Asia Pacific region is projected to provide a safe haven for growth to the market players in the upcoming years.  

Topical Antibiotics Market: Overview

  • According to the latest report published by Transparency Market Research on the global topical antibiotics market for the historical period 2018–2019 and forecast period from 2020 to 2030, high demand for topical antibiotics for the treatment of dermatological conditions is projected to be a major driver for the global topical antibiotics market during the forecast period
  • The global topical antibiotics market was valued at US$ 5.8 Bn in 2019 and is anticipated to expand at a CAGR of ~3% from 2020 to 2030
  • The report analyzes current and future scenario of the global topical antibiotics market
  • The global topical antibiotics market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global topical antibiotics market with respect to the segments based on drug class, dosage form, indication, product type, distribution channel, and region.
  • A detailed qualitative analysis of drivers, restraints, and opportunities of the global topical antibiotics market has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles, along with business overview to understand the competitive landscape in the global topical antibiotics market.
  • This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global topical antibiotics market

Topical Antibiotics Market: Key Drivers & Restraints

  • Increase in Adoption of Topical Antibiotics to Prevent Surgical Site Infections (SSI)
    • Surgical site infection (SSI) is one of the most common complications and a leading cause of hospital acquired infections across the globe. The incidence and prevalence rates are higher in low and middle-income countries.
    • Surgical site infection in spine surgery is one of the most common complications after surgery. Over 40,000 patients in the U.S. report surgical site infection after spine surgery.
    • Several studies have demonstrated that the use of topical antibiotics have significantly reduced the risk of developing surgical site infection. Topical antibiotics provide several advantages over other preventive measures such as use of oral antibiotics, antiseptic, and intravenous antibiotics.
    • Topical antibiotics applied at the surgical site prevent or eliminate bacterial contamination, as the concentration of topical antibiotics exceeds the minimum inhibitory concentration (MIC). Moreover, topical antibiotics are used to reduce bacterial resistance at surgical site.
    • Topical antibiotics are also applied at specific surgical sites. Hence, these reduce the unwanted side effects associated with oral and intravenous antibiotics.
    • Therefore, advantages of topical antibiotics in preventing surgical site infection is likely to fuel the growth of the global market during the forecast period
  • Antimicrobial Resistance to Topical Antibiotics
    • Antimicrobial resistance to a number of topical antibiotics by a large number of infectious pathogens is one of the key restraints of the market
    • Antimicrobial resistance is considered one of the most significant issues in healthcare, and stringent guidelines have been issued by the World Health Organization and respective governing authorities to control the usage of antibiotics and prevent antimicrobial resistance
    • Several factors contribute to the inappropriate usage of topical antibiotics, which leads to the development of antimicrobial resistance

Topical Antibiotics Market: Key Segments

  • In terms of drug class, the global topical antibiotics market has been classified into tetracycline, aminoglycosides, erythromycin, clindamycin, and others
  • Based on dosage form, the global topical antibiotics market has been categorized into ointments, creams, powder, gels, and others
  • In terms of indication, the global topical antibiotics market has been divided into skin infection, eye infection, bromhidrosis, and others
  • Based on product type, the global topical antibiotics market has been bifurcated into prescription and OTC
  • In terms of distribution channel, the global topical antibiotics market has been segregated into hospital pharmacies, retail pharmacies, and others
  • The market size and forecast for each of the segments have been provided in terms of US$ Mn from 2018 to 2030, along with their respective CAGRs for the forecast period from 2020 to 2030, considering 2018 as the base year

Topical Antibiotics Market: Regional Outlook

  • The global topical antibiotics market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of the Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2018 to 2030, along with their respective CAGRs for the forecast period from 2020 to 2030, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • The report profiles the following major players in the global topical antibiotics market based on various attributes such as company overview, financial overview, product types, business strategies, and recent developments. Major companies include
    • Novartis AG
    • GlaxoSmithKline plc
    • Perrigo Company plc
    • Pfizer, Inc
    • Almirall, S.A.
    • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • Medimetriks Pharmaceuticals, Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Mayne Pharma Group Limited.

Topical Antibiotics Market – Segmentation

Drug Class

  • Tetracycline
  • Amino-glycosides
  • Erythromycin
  • Clindamycin
  • Others

Dosage Form

  • Ointments
  • Creams
  • Powder
  • Gels
  • Others

Indication

  • Skin Infection
  • Eye Infection
  • Bromhidrosis
  • Others

Product Type

  • Prescription
  • OTC

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of topical antibiotics market?

The global topical antibiotics market was worth US$ 5.8 Bn and is projected to reach a value of US$ 8.3 Bn by the end of 2030

What is the anticipated CAGR of the topical antibiotics market in the forecast period?

Topical antibiotics market is anticipated to grow at a CAGR of 3% during the forecast period

Which region is expected to project the highest market share in the topical antibiotics market?

North America accounted for a major share of the global topical antibiotics market

What are the key driving factors for the growth of topical antibiotics market?

Topical antibiotics market is driven by increase in incidence rate of dermatological and ophthalmic disorders across the globe and rise in awareness about various skin diseases are projected to drive the market during the forecast period

Who are the key players in the global topical antibiotics market?

Key players in the global topical antibiotics market include Novartis AG, GlaxoSmithKline plc, Perrigo Company plc, Pfizer, Inc., Almirall, S.A., Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.), Medimetriks Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd., and Mayne Pharma Group Limited

    1. Preface 

        1.1. Report Scope and Market Segmentation 

        1.2. Research Highlights

    2. Assumptions and Research Methodology 

        2.1. Assumptions and Acronyms Used

        2.2. Research Methodology

    3. Executive Summary

        3.1. Global Topical Antibiotics Market: Market Snapshot

    4. Market Overview

        4.1. Global Topical Antibiotics Market: Type Overview 

        4.2. Global Topical Antibiotics Market: Key Industry Developments

        4.3. Market Dynamics

        4.4. Drivers and Restraints Snapshot Analysis

        4.5. Drivers

        4.6. Restraints

        4.7. Opportunities

        4.8. Global Topical Antibiotics Market Revenue Projections (US$ Mn), 2018–2030

    5. Key Insights

        5.1. Prevalence of antibiotic resistance

        5.2. Regulatory Scenario by Key Countries

        5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

        5.4. Key Industry Events (Mergers, Acquisitions, Product Launches, Strategic Partnerships, etc.)

        5.5. Total Consumption of Antibiotics (Metric Tones

    6. Global Topical Antibiotics Market Analysis, by Drug Class

        6.1. Introduction

        6.2. Global Topical Antibiotics Market Value and Forecast, by Drug Class

            6.2.1. Tetracycline

            6.2.2. Aminoglycosides

            6.2.3. Erythromycin

            6.2.4. Clindamycin

            6.2.5. Others

        6.3. Global Topical Antibiotics Market Analysis, by Drug Class

        6.4. Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class

    7. Global Topical Antibiotics Market Analysis, by Dosage Form

        7.1. Introduction

        7.2. Global Topical Antibiotics Market Value and Forecast, by Dosage Form

            7.2.1. Ointments

            7.2.2. Creams

            7.2.3. Powder

            7.2.4. Gels

            7.2.5. Others

        7.3. Global Topical Antibiotics Market Analysis, by Dosage Form

        7.4. Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form

    8. Global Topical Antibiotics Market Analysis, by Indication

        8.1. Introduction

        8.2. Global Topical Antibiotics Market Value and Forecast, by Indication

            8.2.1. Skin Infection

            8.2.2. Eye Infection

            8.2.3. Bromhidrosis

            8.2.4. Others

        8.3. Global Topical Antibiotics Market Analysis, by Indication

        8.4. Global Topical Antibiotics Market Attractiveness Analysis, by Indication

    9. Global Topical Antibiotics Market Analysis, by Product Type

        9.1. Introduction

        9.2. Global Topical Antibiotics Market Value and Forecast, by Product Type

            9.2.1. Prescription

            9.2.2. OTC

        9.3. Global Topical Antibiotics Market Analysis, by Product Type

        9.4. Global Topical Antibiotics Market Attractiveness Analysis, by Product Type

    10. Global Topical Antibiotics Market Analysis, by Distribution Channel

        10.1. Introduction

        10.2. Global Topical Antibiotics Market Value and Forecast, by Distribution Channel

            10.2.1. Hospital Pharmacies

            10.2.2. Retail Pharmacies

            10.2.3. Others

        10.3. Global Topical Antibiotics Market Analysis, by Distribution Channel

        10.4. Global Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel

    11. Global Topical Antibiotics Market Analysis, by Region

        11.1. Global Topical Antibiotics Market Value and Forecast, by Region, 2018–2030 

            11.1.1. North America

            11.1.2. Europe

            11.1.3. Asia Pacific

            11.1.4. Latin America

            11.1.5. Middle East & Africa

        11.2. Global Topical Antibiotics Market Analysis, by Region

        11.3. Global Topical Antibiotics Market Attractiveness Analysis, by Region

    12. North America Topical Antibiotics Market Analysis

        12.1. North America Topical Antibiotics Market 

        12.2. North America Topical Antibiotics Market Overview

        12.3. North America Topical Antibiotics Market Value and Forecast, by Drug Class

            12.3.1. Tetracycline

            12.3.2. Aminoglycosides

            12.3.3. Erythromycin

            12.3.4. Clindamycin

            12.3.5. Others

        12.4. North America Topical Antibiotics Market Value and Forecast, by Dosage Form

            12.4.1. Ointments

            12.4.2. Creams

            12.4.3. Powder

            12.4.4. Gels

            12.4.5. Others

        12.5. North America Topical Antibiotics Market Value and Forecast, by Indication

            12.5.1. Skin Infection

            12.5.2. Eye Infection

            12.5.3. Bromhidrosis

            12.5.4. Others

        12.6. North America Topical Antibiotics Market Value and Forecast, by Product Type

            12.6.1. Prescription

            12.6.2. OTC

        12.7. North America Topical Antibiotics Market Value and Forecast, by Distribution Channel

            12.7.1. Hospital Pharmacies

            12.7.2. Retail Pharmacies

            12.7.3. Others

        12.8. North America Topical Antibiotics Market Forecast, by Country

            12.8.1. U.S.

            12.8.2. Canada

        12.9. North America Topical Antibiotics Market Attractiveness Analysis 

            12.9.1. By Product Type

            12.9.2. By Application 

            12.9.3. By Distribution Channel

            12.9.4. By Country

    13. Europe Topical Antibiotics Market Analysis

        13.1. Europe Topical Antibiotics Market 

        13.2. Europe Topical Antibiotics Market Overview

        13.3. Europe Topical Antibiotics Market Value and Forecast, by Drug Class

            13.3.1. Tetracycline

            13.3.2. Aminoglycosides

            13.3.3. Erythromycin

            13.3.4. Clindamycin

            13.3.5. Others

        13.4. Europe Topical Antibiotics Market Value and Forecast, by Dosage Form

            13.4.1. Ointments

            13.4.2. Creams

            13.4.3. Powder

            13.4.4. Gels

            13.4.5. Others

        13.5. Europe Topical Antibiotics Market Value and Forecast, by Indication

            13.5.1. Skin Infection

            13.5.2. Eye Infection

            13.5.3. Bromhidrosis

            13.5.4. Others

        13.6. Europe Topical Antibiotics Market Value and Forecast, by Product Type

            13.6.1. Prescription

            13.6.2. OTC

        13.7. Europe Topical Antibiotics Market Value and Forecast, by Distribution Channel

            13.7.1. Hospital Pharmacies

            13.7.2. Retail Pharmacies

            13.7.3. Others

        13.8. Europe Topical Antibiotics Market Forecast, by Country/Sub-region

            13.8.1. U.K.

            13.8.2. France

            13.8.3. Germany

            13.8.4. Spain

            13.8.5. Italy

            13.8.6. Rest of Europe

        13.9. Europe Topical Antibiotics Market Attractiveness Analysis 

            13.9.1. By Product Type

            13.9.2. By Application

            13.9.3. By Route of Administration

            13.9.4. By Distribution Channel

            13.9.5. By Country/Sub-region

    14. Asia Pacific Topical Antibiotics Market Analysis

        14.1. Asia Pacific Topical Antibiotics Market 

        14.2. Asia Pacific Topical Antibiotics Market Overview

        14.3. Asia Pacific Topical Antibiotics Market Value and Forecast, by Drug Class

            14.3.1. Tetracycline

            14.3.2. Aminoglycosides

            14.3.3. Erythromycin

            14.3.4. Clindamycin

            14.3.5. Others

        14.4. Asia Pacific Topical Antibiotics Market Value and Forecast, by Dosage Form

            14.4.1. Ointments

            14.4.2. Creams

            14.4.3. Powder

            14.4.4. Gels

            14.4.5. Others

        14.5. Asia Pacific Topical Antibiotics Market Value and Forecast, by Indication

            14.5.1. Skin Infection

            14.5.2. Eye Infection

            14.5.3. Bromhidrosis

            14.5.4. Others

        14.6. Asia Pacific Topical Antibiotics Market Value and Forecast, by Product Type

            14.6.1. Prescription

            14.6.2. OTC

        14.7. Asia Pacific Topical Antibiotics Market Value and Forecast, by Distribution Channel

            14.7.1. Hospital Pharmacies

            14.7.2. Retail Pharmacies

            14.7.3. Others

        14.8. Asia Pacific Topical Antibiotics Market Forecast, by Country/Sub-region

            14.8.1. China

            14.8.2. India

            14.8.3. Japan

            14.8.4. Australia & New Zealand

            14.8.5. Rest of Asia Pacific

        14.9. Asia Pacific Topical Antibiotics Market Attractiveness Analysis 

            14.9.1. By Product Type

            14.9.2. By Application

            14.9.3. By Distribution Channel

            14.9.4. By Country/Sub-region

    15. Latin America Topical Antibiotics Market Analysis

        15.1. Latin America Topical Antibiotics Market 

        15.2. Latin America Topical Antibiotics Market Overview

        15.3. Latin America Topical Antibiotics Market Value and Forecast, by Drug Class

            15.3.1. Tetracycline

            15.3.2. Aminoglycosides

            15.3.3. Erythromycin

            15.3.4. Clindamycin

            15.3.5. Others

        15.4. Latin America Topical Antibiotics Market Value and Forecast, by Dosage Form

            15.4.1. Ointments

            15.4.2. Creams

            15.4.3. Powder

            15.4.4. Gels

            15.4.5. Others

        15.5. Latin America Topical Antibiotics Market Value and Forecast, by Indication

            15.5.1. Skin Infection

            15.5.2. Eye Infection

            15.5.3. Bromhidrosis

            15.5.4. Others

        15.6. Latin America Topical Antibiotics Market Value and Forecast, by Product Type

            15.6.1. Prescription

            15.6.2. OTC

        15.7. Latin America Topical Antibiotics Market Value and Forecast, by Distribution Channel

            15.7.1. Hospital Pharmacies

            15.7.2. Retail Pharmacies

            15.7.3. Others

        15.8. Latin America Topical Antibiotics Market Forecast, by Country/Sub-region

            15.8.1. Brazil

            15.8.2. Mexico

            15.8.3. Rest of Latin America

        15.9. Latin America Topical Antibiotics Market Attractiveness Analysis 

            15.9.1. By Product Type

            15.9.2. By Application

            15.9.3. By Distribution Channel

            15.9.4. By Country/Sub-region

    16. Middle East & Africa Topical Antibiotics Market Analysis

        16.1. Middle East & Africa Topical Antibiotics Market 

        16.2. Middle East & Africa Topical Antibiotics Market Overview

        16.3. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Drug Class

            16.3.1. Tetracycline

            16.3.2. Aminoglycosides

            16.3.3. Erythromycin

            16.3.4. Clindamycin

            16.3.5. Others

        16.4. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Dosage Form

            16.4.1. Ointments

            16.4.2. Creams

            16.4.3. Powder

            16.4.4. Gels

            16.4.5. Others

        16.5. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Indication

            16.5.1. Skin Infection

            16.5.2. Eye Infection

            16.5.3. Bromhidrosis

            16.5.4. Others

        16.6. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Product Type

            16.6.1. Prescription

            16.6.2. OTC

        16.7. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Distribution Channel

            16.7.1. Hospital Pharmacies

            16.7.2. Retail Pharmacies

            16.7.3. Others

        16.8. Middle East & Africa Topical Antibiotics Market Forecast, by Country/Sub-region

            16.8.1. GCC Countries

            16.8.2. South Africa

            16.8.3. Rest of Middle East & Africa

        16.9. Middle East & Africa Topical Antibiotics Market Attractiveness Analysis 

            16.9.1. By Product Type

            16.9.2. By Application

            16.9.3. By Distribution Channel

            16.9.4. By Country/Sub-region

    17. Competitive Landscape 

        17.1. Company Profiles

            17.1.1. Novartis AG

                17.1.1.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.1.2. Financials

                17.1.1.3. Recent Developments

                17.1.1.4. Strategy

            17.1.2. GlaxoSmithKline plc

                17.1.2.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.2.2. Financials

                17.1.2.3. Recent Developments

                17.1.2.4. Strategy

            17.1.3. Perrigo Company plc

                17.1.3.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.3.2. Financials

                17.1.3.3. Recent Developments

                17.1.3.4. Strategy

            17.1.4. Pfizer, Inc.

                17.1.4.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.4.2. Financials

                17.1.4.3. Recent Developments

                17.1.4.4. Strategy

            17.1.5. Almirall, S.A.

                17.1.5.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.5.2. Financials

                17.1.5.3. Recent Developments

                17.1.5.4. Strategy

            17.1.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.) 

                17.1.6.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.6.2. Financials

                17.1.6.3. Recent Developments

                17.1.6.4. Strategy

            17.1.7. Medimetriks Pharmaceuticals, Inc.

                17.1.7.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.7.2. Financials

                17.1.7.3. Recent Developments

                17.1.7.4. Strategy

            17.1.8. Taro Pharmaceutical Industries Ltd.

                17.1.8.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.8.2. Financials

                17.1.8.3. Recent Developments

                17.1.8.4. Strategy

            17.1.9. Mayne Pharma Group Limited 

                17.1.9.1. Overview (HQ, Employee Strength, Business Segments)

                17.1.9.2. Financials

                17.1.9.3. Recent Developments

                17.1.9.4. Strategy

    List of Tables

    TABLE 1 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

    TABLE 2 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

    TABLE 3 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030

    TABLE 4 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    TABLE 5 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

    TABLE 6 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Region, 2018–2030

    TABLE 7 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Country, 2018–2030

    TABLE 8 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

    TABLE 9 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

    TABLE 10 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030

    TABLE 11 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    TABLE 12 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

    TABLE 13 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    TABLE 14 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class 2018–2030

    TABLE 15 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

    TABLE 16 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication 2018–2030

    TABLE 17 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type2018–2030

    TABLE 18 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel 2018–2030

    TABLE 19 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    TABLE 20 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

    TABLE 21 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

    TABLE 22 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Indication, 2018–2030

    TABLE 23 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2018–2030

    TABLE 24 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030

    TABLE 25 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    TABLE 26 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

    TABLE 27 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

    TABLE 28 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030

    TABLE 29 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    TABLE 30 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

    TABLE 31 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    TABLE 32 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

    TABLE 33 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

    TABLE 34 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030

    TABLE 35 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    TABLE 36 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

    List of Figures

    Figure 1: Global Topical Antibiotics Market Value (US$ Mn) Forecast, 2018–2030

    Figure 2: Global Topical Antibiotics Market, by Drug Class, 2019

    Figure 3: Global Topical Antibiotics Market Value Share, by Dosage Form, 2019

    Figure 4: Global Topical Antibiotics Market Value Share, by Indication, 2019

    Figure 5: Global Topical Antibiotics Market, by Product Type, 2019

    Figure 6: Global Topical Antibiotics Market Value Share, by Region, 2019

    Figure 7: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2019

    Figure 8: Global Topical Antibiotics Market Value Share Analysis, by Drug Class, 2018 and 2027

    Figure 9: Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020-2030

    Figure 10: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tetracycline, 2018–2030

    Figure 11: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Aminoglycosides, 2018–2030

    Figure 12: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Erythromycin, 2018–2030

    Figure 13: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Clindamycin, 2018–2030

    Figure 14: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030

    Figure 15: Global Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030

    Figure 16: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030

    Figure 17: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Ointments, 2018–2030

    Figure 18: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Creams, 2018–2030

    Figure 19: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Powder, 2018–2030

    Figure 20: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Gels, 2018–2030

    Figure 21: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030

    Figure 22: Global Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030

    Figure 23: Global Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030

    Figure 24: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Skin Infection, 2018–2030

    Figure 25: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Eye Infection, 2018–2030

    Figure 26: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Bromhidrosis, 2018–2030

    Figure 27: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030

    Figure 28: Global Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 29: Global Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 30: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Prescription, 2018–2030

    Figure 31: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by OTC, 2018–2030

    Figure 32: Global Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

    Figure 33: Global Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

    Figure 34: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030

    Figure 35: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030

    Figure 36: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030

    Figure 37: Global Topical Antibiotics Market Value Share Analysis, by Region, 2019 and 2030

    Figure 38: Global Topical Antibiotics Market Attractiveness Analysis, by Region, 2020–2030

    Figure 39: North America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030

    Figure 40: North America Topical Antibiotics Market Value Share Analysis, by Country, 2019 and 2030

    Figure 41: North America Topical Antibiotics Market Attractiveness Analysis, by Country, 2020–2030

    Figure 42: North America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030

    Figure 43: North America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030

    Figure 44: North America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030

    Figure 45: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030

    Figure 46: North America Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030

    Figure 47: North America Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030

    Figure 48: North America Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 49: North America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 50: North America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

    Figure 51: North America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

    Figure 52: Europe Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030

    Figure 53: Europe Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 54: Europe Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 55: Europe Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030

    Figure 56: Europe Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030

    Figure 57: Europe Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030

    Figure 58: Europe Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030

    Figure 59: Europe Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030

    Figure 60: Europe Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030

    Figure 61: Europe Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 62: Europe Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 63: Europe Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

    Figure 64: Europe Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

    Figure 65: Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030

    Figure 66: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 67: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 68: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030

    Figure 69: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030

    Figure 70: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030

    Figure 71: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030

    Figure 72: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030

    Figure 73: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030

    Figure 74: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 75: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 76: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

    Figure 77: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

    Figure 78: Latin America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030

    Figure 79: Latin America Topical Antibiotics Market Value Share, by Country/Sub-region, 2019 and 2030

    Figure 80: Latin America Topical Antibiotics Market Attractiveness, by Country/Sub-region, 2020–2030

    Figure 81: Latin America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030

    Figure 82: Latin America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030

    Figure 83: Latin America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030

    Figure 84: Latin America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030

    Figure 85: Latin America Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030

    Figure 86: Latin America Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030

    Figure 87: Latin America Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 88: Latin America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 89: Latin America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

    Figure 90: Latin America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

    Figure 91: Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030

    Figure 92: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 93: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 94: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030

    Figure 95: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030

    Figure 96: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030

    Figure 97: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030

    Figure 98: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030

    Figure 99: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030

    Figure 100: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 101: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 102: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030

    Figure 103: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Copyright © Transparency Market Research, Inc. All Rights reserved

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy